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Abstract
Although research suggests that hyperhomocysteinemia (Hhcy) influences the development of
cardiovascular disease, the hypothesis that Hhcy specifically causes hypertension remains a
relatively mysterious subject. Despite the suggestion that Hhcy is linked to hypertension, there
currently are no guidelines on hypertension treatment related to serum homocysteine
concentration.
The following case discusses a 67-year-old Caucasian female with recently diagnosed
hypertension. She presents to her primary care clinic for a three-week follow-up exam after
beginning an antihypertensive regimen in accord with her diagnosis of essential hypertension.
Her blood pressure remains uncontrolled, despite pharmacologic intervention.
Hypertension is an illness seen commonly in primary care. Hypertension that is poorly controlled
increases the risk of cardiovascular complications such as myocardial infarction, stroke, and
heart failure; therefore, it is necessary to be knowledgeable about the causes and treatments of
hypertension.
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Background
A 67-year-old Caucasian female presented to the clinic for a three-week follow-up after a
recent diagnosis of essential hypertension, for which she was started on antihypertensive therapy.
She reports a history of smoking, but has no additional past medical history. However, her family
history is significant for coronary artery disease and diabetes. Despite pharmacologic
antihypertensive therapy in conjunction with an active lifestyle, her blood pressure remains
elevated.
Hypertension has long been recognized as a modifiable risk factor for heart disease. The
etiology of hypertension is not yet fully understood, but remains important as its prevalence
continues to grow worldwide (Wang et al, 2014). For decades, there have been studies looking at
the relationship between homocysteine levels and the risk of cardiovascular disease. More
recently, elevated homocysteine, or hyperhomocysteinemia (Hhcy), has been viewed as a risk
factor for elevated blood pressure in adults. It is necessary to consider the relationship between
homocysteine and blood pressure as studies have proven that interventions (such as
supplementation of folic acid) can reduce serum levels of homocysteine (Anderson, Ha Jee,
Charleston, Narrett, & Appel, 2010). If, in fact, Hhcy can be linked to hypertension, it would be
prudent for providers to know how to diagnose and treat this condition.
Case Report
History
A 67-year-old Caucasian female presents to the clinic for a follow-up exam after a recent
diagnosis of essential hypertension. She was started on antihypertensive therapy three weeks ago,
which consisted of Lisinopril 20 mg once daily. She has been monitoring her blood pressure
daily, with an average systolic blood pressure reading in the 150’s.
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At this visit, she is feeling well except for a persistent dry cough, which has been present
for the past three weeks. When asked about associated symptoms, she reports no fever, chills,
wheezing, shortness of breath, or upper respiratory symptoms. She reports no increased anxiety
or stress, and states “other than this cough, nothing has seemed out of the ordinary”. She does not
mention that her cough is worse with exertion, nor does it interfere with daily activities. Other
pertinent negatives include no chest pain, palpitations, dizziness, or syncope.
Other than newly diagnosed hypertension, she denies comorbidities including
dyslipidemia or diabetes. She gives a brief overview of her family history, which is concerning
as both parents have undergone coronary artery bypass graft, indicating significant coronary
artery disease. After mentioning this, she explains that at age 53 she had an episode of chest pain,
which eventually led to an angiogram. Regarding the angiogram, she recalls “the cardiologist
told me my arteries were clean at that time”. Her family history also includes a brother with
diabetes.
She is currently retired and lives an active lifestyle. She loves to swim, often 6 miles at a
time, and participates in a water aerobics class at a nearby gym, three to four days per week. She
has a 30 pack-year history of smoking, having quit more than 10 years ago. She does not
consume alcohol and has never used any other form of drugs.
Her current medications include Lisinopril 20 mg once daily, in addition to a daily
multivitamin. She uses no other over-the-counter or herbal medications, and denies any drug
allergies.
Physical Exam, Diagnosis, and Treatment Plan
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The following vital signs are obtained at this visit: Blood pressure 160/98, heart rate 80,
respiratory rate 20, and temperature 98.6 F. During her exam, she is pleasant and engaged in
conversation, showing no signs of distress.
The physical exam at this visit reveals clear conjunctiva without drainage, and pupils that
are equal, round, and reactive to light and accommodation, bilaterally. Her funduscopic exam is
unremarkable, bilaterally. No nasal mucosa inflammation or discharge is noted, which aids in
ruling out an upper respiratory cause of her cough. Her oropharynx is pink, moist, and free of
lesions or exudate. Her neck is supple, non-tender, and without masses. Her cardiovascular exam
reveals a regular heart rate and rhythm, with no evidence of a murmur or adventitious heart
sounds. Trace peripheral edema is noted to the lower extremities. Her breathing is regular and
non-labored during the exam. Lung sounds are clear throughout all lung fields, with no wheezing
or crackles noted. Her abdominal assessment is negative. She is alert and oriented to person,
place, and time. Her skin is warm and dry to touch with no evidence of rash, bruising, or
wounds.
No laboratory testing or diagnostics were obtained at this visit. Given the patient’s history
and physical exam which indicate no signs of an infectious process, it is likely that her persistent
dry cough is related to the ACE inhibitor started three weeks prior. After determining that her
cough is likely an adverse effect of an ACE inhibitor, Lisinopril is discontinued. She is informed
that her blood pressure should be less than 150/90, per JNC-8 guidelines on the treatment of
hypertension. As such, she will need to start an antihypertensive from another drug class. In
further reference to the JNC-8 guidelines on management of high blood pressure,
Hydrochlorothiazide 25 mg once daily is prescribed (James et al., 2014). The patient is given
information on this new prescription and questions are answered. She is encouraged to continue
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water aerobics three to four days a week, and may monitor her blood pressure at home as
desired. She is recommended to follow-up in four weeks for a recheck of her blood pressure, as
well as lab work, due to the potential for Hydrochlorothiazide to alter electrolytes and renal
function. Additionally, a fasting lipid panel will be ordered at her follow-up visit due to a
significant family history of coronary artery disease, as well as a personal history of smoking.
The patient is instructed to follow-up sooner than four weeks if her cough does not improve, or if
she develops other concerning symptoms. She agrees with this treatment plan, and with followup related to her diagnosis of hypertension.
As demonstrated in the previously discussed case report, treatment for hypertension is not
always straightforward. Many factors play into the cause of hypertension, factors which may
vary among individuals and alter treatment outcomes. It is important for providers to understand
what factors influence hypertension, as having that understanding will allow for the most
appropriate treatment to be given. In the past century, homocysteine was discovered to be a
contributing factor in cardiovascular disease. In more recent years, research has also looked at
how increased levels of homocysteine may directly affect blood pressure (Li et al., 2016).
Literature Review
Hyperhomocysteinemia has been investigated by researchers as a possible cause of
hypertension in adults. To better understand how Hhcy may affect the cardiovascular system, it
is essential to first understand what homocysteine is. Homocysteine is an amino acid which
contains a sulphur compound formed via the biosynthesis of cysteine and methionine (also
amino acids). It is largely formed via the replacement of a molecule from the amino acid
methionine. Methionine is found to be plentiful in animal proteins (Ganguly & Alam, 2015). The
most common causes of Hhcy are due to genetic or environmental reasons. For example, a
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deficiency in vitamin B12 or folic acid can inhibit the ability of homocysteine to be broken
down, rendering increased intracellular concentrations. The sulphur component found in
homocysteine can cause oxidative damage, or the inhibition of antioxidant properties, within the
tissues so the body cannot counteract the harmful effects of free radicals. Therefore, Hhcy can
cause a hypercoagulable state and rapid proliferation (i.e. reproduction) of smooth muscle cells.
Rapid proliferation of smooth muscle cells in the vessel endothelium may cause arterial stiffness
and thus hypertension (Korzeniowska, Cieslewicz, Chmara, & Jablecka, 2015).
Hyperhomocysteinemia is defined as a serum homocysteine level greater than 15 umol/L.
Most healthy persons have a homocysteine level between 5.0 and 15.0 umol/L, depending on the
method being used to interpret this value. A homocysteine level between 16 and 30 umol/L is
defined as moderate, a level between 31 and 100 is reported as intermediate, and severe Hhcy is
considered any value above 100 umol/L (Ganguly, 2015). As one source reports, the normal
range for serum homocysteine concentration tends to increase with age. Consequently, this
places adults at an increasing risk of Hhcy as they age (Korzeniowska et al., 2015). In caring for
an aging adult population, the ability to determine the presence of Hhcy becomes important, as
this may affect blood pressure.
There are many reasons to consider the relationship between Hhcy and hypertension,
with perhaps the most important reason being a reduction in the risk of cardiovascular morbidity
and mortality (Lionakis, Mendrinos, Sanidas, Favatas, & Georgopoulou, 2012). Making the
connection between Hhcy and blood pressure will aid in the development of hypertension
treatment plans to reduce serum homocysteine levels.
The review of literature surrounding this topic led to several types of studies that have
been performed in multiple countries, with most studies being investigated in China. Although it
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is not recent, the Framingham Heart Study, originally published in 2003, was the first study to
look at whether increased serum homocysteine levels caused hypertension. The relevance of this
source is proven through its frequent citation within more recent studies, and so, should be
discussed within this case report. At the time that this prospective longitudinal study was
completed, several cross-sectional studies had observed an increased risk of cardiovascular
disease in the presence of Hhcy, but none had looked at whether it was the cause of high blood
pressure (Sundstrom et al., 2003).
The goal of the Framingham Heart study, was to investigate the progression of blood
pressure in relation to serum homocysteine, over a four-year follow-up. Homocysteine levels
were analyzed based on the following criteria: as sex-based quartiles; as Hhcy (which was
considered > 14 umol/L); and as models with multiple variables known to influence blood
pressure (i.e. diabetes mellitus, obesity, smoking, creatinine level, and blood pressure category).
At the four-year follow-up exam, 360 of the 2,104 participants had developed hypertension.
Rates were similar among genders, and those with homocysteine levels above 14 umol/L had a
higher incidence of hypertension. However, in the models that had been adjusted for age and sex,
and in the models with multiple variables, the correlation between homocysteine level and blood
pressure elevation was not statistically significant. And so, the Framingham Heart Study
concludes that Hhcy is likely a concomitant finding, rather than a causative factor in the
development of hypertension (Sundstrom et al., 2003).
Per Ganguly and Alam (2015) the role of homocysteine in the control of blood pressure
deserves some attention, as blood pressure may facilitate the toxic effects of homocysteine on the
cardiovascular system. Experimental and animal studies have shown a link between
homocysteine and hypertension when an increase in blood pressure was seen after inducing
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hyperhomocysteinemia. The resulting increase in blood pressure may be due to changes in
vascular endothelial integrity. Cell culture studies performed in artificial environments have
shown that with the administration of homocysteine, there was induction of oxidative stress to
the vascular endothelium and decreased availability of nitric oxide. Without the vasodilatory
effect of nitric oxide, the endothelium was less able to react to vasoconstriction, which increased
blood pressure. This study also reports that impairments in vascular endothelium vasodilation
have been noted in humans with acute or chronic Hhcy, suggesting that Hhcy does in fact
contribute to hypertension (Ganguly & Alam, 2015).
In further review of the literature, similar findings were discussed in the European
Journal of Physiology, regarding the hypothesis of vascular endothelial injury due to oxidative
stress. Peripheral circulation is, in part, controlled by both vasodilatory and vasoconstricting
factors such as nitric oxide and oxidative stress, respectively. Hhcy influences peripheral blood
flow primarily by impairing the actions of such vasodilators. A confounding effect is that Hhcy
contributes to oxidative stress, which works against nitric oxide, so it is not able to generate its
full potential of vasodilation. In one study, adults were given oral methionine which increased
their homocysteine level and resulted in a reduction in flow-mediated vasodilation of the
endothelium within the brachial artery. The reduction in dilation was significant, compared to
adults with low levels of homocysteine. Thus, signifying that Hhcy is an independent risk factor
for decreased function of arterial endothelium, and so a risk for hypertension. Two additional
studies have found that oral methionine increases homocysteine levels, and impairs the action of
endothelial dilatation in healthy adults. The findings of this study indicate that there is a positive
correlation between Hhcy and alteration of vessel endothelium, which may cause arterial
stiffness and hypertension (Toda & Okamura, 2016).
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Korzeniowska et al. (2015) discuss, as many other studies have, the effects of endothelial
dysfunction in the presence of elevated homocysteine levels. With that background, the authors
of this study looked at the relation of homocysteine levels, to newly diagnosed essential
hypertension in adults. Age and smoking were considered associated factors in this study. The
patients who fell into the essential hypertension category per JNC VII criteria, had shown higher
serum homocysteine (mean 15.23 umol/L) compared to the control group (mean 9.71 umol/L).
Among participants, 28 percent had a homocysteine level of 15 umol/L or greater. Also, in those
with hypertension who were smokers, homocysteine levels were higher than non-smokers. Age
was the only factor shown to correlate with homocysteine level in healthy participants without
hypertension (Korzeniowska et al., 2015).
A prospective Kailuan study, looked at homocysteine levels and the progression of blood
pressure among a community cohort of 2427 men and women, over 2 years. Within the male
cohort, the incidence of hypertension was most significant at a lower homocysteine level, and
showed reduced progression of hypertension as homocysteine levels increased. Within the
female cohort, there was not a significant correlation found between homocysteine level and
blood pressure. This 2-year longitudinal study concluded that rather than Hhcy increasing the
risk of hypertension, lower homocysteine levels might be a risk factor for the occurrence of high
blood pressure (Wang et al., 2014).
In Northeast rural China, a large cross-sectional study looked at the independent
association of Hhcy and hypertension among 7,130 people aged 35 years and older within the
general population. Upon completion, a trend was seen between increased levels of
homocysteine and the incidence of hypertension. After adjusting for patient variables such as
age, body mass index, smoking, family history of hypertension, and comorbidities, the findings
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of several logistic regression analyses demonstrated a significant association of Hhcy and high
blood pressure among males, but this association was not seen in females. In addition, the
prevalence of Hhcy was much higher in males than females, with a mean homocysteine level in
men of 20.99 umol/L and 14.19 umol/L in women. Interestingly, the mean level of homocysteine
in males within this study is significantly higher than the mean typically reported among studies
completed in other countries, suggesting that future research should investigate environmental or
cultural factors associated with homocysteine levels. The results of this study concluded that
there was a positive correlation between Hhcy and the prevalence of hypertension in males, and
that homocysteine levels tend to be higher in males than females (Li et al., 2016).
It has been noted within multiple studies, that folate intake may reduce blood pressure as
it increases the activity of nitric oxide, which leads to vasodilation of vessels and reduced serum
homocysteine levels (Anderson et al., 2010; Toda & Okamura, 2016; Van Dijk et al., 2015; Xun
et al., 2012). One study looked at how the ingestion of folate affected the incidence of
hypertension among young African American and Caucasian adults, over a 20-year follow-up.
This follow-up study used data obtained from 6 follow-ups of the Coronary Artery Risk
Development in Young Adults (CARDIA) study, which examined the progression of
cardiovascular disease based on risk factors. While this study was directly focused on the link
between hypertension and folate intake, it also assessed the relation between folate and
homocysteine levels, looking for a potential mechanism as to why the former link exists. Of
importance, were the examinations of how serum levels of folate related to homocysteine levels,
how homocysteine concentration related to blood pressure, and the relation of serum
homocysteine to newly diagnosed hypertension. The study found an inverse link between the
level of folate in the blood and the level of homocysteine. Participants with higher levels of
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folate had lower serum concentrations of homocysteine, and a lower incidence of hypertension.
Furthermore, as homocysteine levels increased by 5 umol/L, systolic blood pressure increased by
0.63 mmHg and diastolic blood pressure increased by 0.55 mmHg. Despite being unable to
prove whether folate directly reduced serum homocysteine concentrations, the study did find that
higher rates of hypertension were noted among those with higher concentrations of homocysteine
(Xun et al., 2012).
Finally, although multiple studies make note of the hypothesis that Hhcy may contribute
to hypertension, studies have failed to prove a strong predictable causation between Hhcy and
hypertension. The literature available on this topic is insufficient, especially works within the
past decade, indicating that further investigation is needed. It was found that Hhcy has been
linked to an increased risk of atherosclerosis, heart failure, and stroke. The correlation between
Hhcy and the previously mentioned cardiovascular diseases, provides plausible reason to
continue researching the relationship between Hhcy and hypertension.
Learning points
•

Hhcy has been proven in some instances to cause harm to vascular endothelial integrity
via oxidative stress, owing to arterial stiffness which may contribute to hypertension.

•

The relationship between Hhcy and hypertension in adults are conflicting among studies,
thus a definitive correlation cannot be made between the two.

•

There is a lack of high level evidence studies surrounding the topic of Hhcy and its effect
on hypertension in adults.

•

It is suggested that future studies include monitoring of serum nitric oxide levels in
participants, as this may give further insight to the relationship between Hhcy and
hypertension.
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